Zenfold and Ginkgo collaborate to enable veterinary active ingredient development 

This partnership aims to replace traditional chemical processes in veterinary active ingredient production with a sustainable biological method

Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing speciality ingredients using sustainable technologies and precision fermentation, announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufacturing of veterinary products. This partnership aims to replace traditional chemical processes in veterinary active ingredient production with a sustainable biological method.

“This collaboration marks a significant step forward in Zenfold’s mission to bring sustainable manufacturing technology to the veterinary medicine industry,” said Dr. BSV Prasad, CEO and Managing Director of Zenfold Sustainable Technologies. “By utilising Ginkgo’s expertise and innovation, we are well-positioned to develop a sustainable solution that will have a lasting impact on the Indian market and beyond.”

“We are excited to partner with Zenfold, which brings a powerful vision of sustainable biotechnology to veterinary active ingredient development. This collaboration will enable us to apply our state-of-the-art enzyme discovery module to enable more innovation in the veterinary medicine space,” said Jennifer Wipf, SVP, Head of Commercial, Cell Engineering at Ginkgo. “The project involves creating a broad library of cDNA candidates from a metagenomic collection of billions of enzyme sequences. That’s the kind of scale visionary projects like this need, and Ginkgo is committed to scaling up this solution for the betterment of animal health and the environment.”

This partnership aims to replace traditional chemical